Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.48 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.48 |
| ▸ | OXER1 | Q8TDS5 | 4/20 | 0.48 |
| ▸ | PPARG | P37231 | 3/20 | 0.48 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | RXRA | P19793 | 2/20 | 0.48 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.48 |
| ▸ | F7 | P08709 | 3/20 | 0.44 |
| ▸ | F3 | P13726 | 3/20 | 0.44 |
| ▸ | PPARA | Q07869 | 3/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | PPARD | Q03181 | 2/20 | 0.44 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.44 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6474724 | 1.00 | — | — | |
| SCHEMBL1199081 | 1.00 | — | — | |
| SCHEMBL1325015 | 1.00 | — | — | |
| SCHEMBL1325012 | 1.00 | — | — | |
| SCHEMBL6473956 | 1.00 | — | — | |
| SCHEMBL19293246 | 1.00 | ALDH1A1 (0.48) | ALDH1A1CYP19A1OXER1PPARGMAPT | |
| SCHEMBL23143217 | 1.00 | ALDH1A1 (0.48) | ALDH1A1CYP19A1OXER1PPARGMAPT | |
| SCHEMBL6473577 | 1.00 | — | — | |
| SCHEMBL20834321 | 1.00 | ALDH1A1 (0.48) | ALDH1A1CYP19A1OXER1PPARGMAPT | |
| SCHEMBL1325013 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250188006-A1 | 13C-LABELLED CHLORINATED PARAFFINS AND THEIR PREPARATION | CHIRON AS (NO) | 2025-06-12 | — | — | US | disclosed |
| EP-4493530-A1 | 13 C-LABELLED CHLORINATED PARAFFINS AND THEIR PREPARATION | Chiron AS (NO) | 2025-01-22 | — | — | EP | disclosed |
| US-11795124-B2 | Renewable alkene production engaging metathesis | NESTE OYJ (FI) | 2023-10-24 | — | — | US | disclosed |
| WO-2023174709-A1 | 13C-LABELLED CHLORINATED PARAFFINS AND THEIR PREPARATION | CHIRON AS (NO) | 2023-09-21 | — | — | WO | disclosed |
| EP-4245742-A1 | 13C-LABELLED CHLORINATED PARAFFINS AND THEIR PREPARATION | Chiron AS (NO) | 2023-09-20 | — | — | EP | disclosed |
| US-11643616-B2 | Renewable base oil production engaging metathesis | NESTE OYJ (FI) | 2023-05-09 | — | — | US | disclosed |
| US-20220363613-A1 | RENEWABLE ALKENE PRODUCTION ENGAGING METATHESIS | NESTE OYJ (FI) | 2022-11-17 | — | — | US | disclosed |
| US-20220340835-A1 | RENEWABLE BASE OIL PRODUCTION ENGAGING METATHESIS | NESTE OYJ (FI) | 2022-10-27 | — | — | US | disclosed |
| EP-4034522-A1 | RENEWABLE ALKENE PRODUCTION ENGAGING METATHESIS | Neste Oyj (FI) | 2022-08-03 | — | — | EP | disclosed |
| EP-4034613-A1 | RENEWABLE BASE OIL PRODUCTION ENGAGING METATHESIS | Neste Oyj (FI) | 2022-08-03 | — | — | EP | disclosed |
| CN-114787117-A | Renewable olefin production involving metathesis reactions | 耐思特公司 | 2022-07-22 | — | — | CN | disclosed |
| CN-114430772-A | Production of renewable base oils participating in metathesis | 耐思特公司 | 2022-05-03 | — | — | CN | disclosed |
| WO-2021058876-A1 | RENEWABLE ALKENE PRODUCTION ENGAGING METATHESIS | NESTE OYJ (FI) | 2021-04-01 | — | — | WO | disclosed |
| WO-2021058875-A1 | RENEWABLE BASE OIL PRODUCTION ENGAGING METATHESIS | NESTE OYJ (FI) | 2021-04-01 | — | — | WO | disclosed |
| EP-3388483-A1 | PROPYLENE RESIN COMPOSITION AND INJECTION MOLDED ARTICLE | Sumitomo Chemical Company, Ltd (JP) | 2018-10-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220340835-A1 | RENEWABLE BASE OIL PRODUCTION ENGAGING METATHESIS | FASN, DGAT2, GK | ALDH1A1 626/4885CYP19A1 734/4885OXER1 542/4885 |
| US-20220363613-A1 | RENEWABLE ALKENE PRODUCTION ENGAGING METATHESIS | FASN, DGAT2, DGAT1 | ALDH1A1 202/4885CYP19A1 608/4885OXER1 420/4885 |
| US-20250188006-A1 | 13C-LABELLED CHLORINATED PARAFFINS AND THEIR PREPARATION | PCNA, CAT, CDC73 | ALDH1A1 2230/4885CYP19A1 496/4885OXER1 2135/4885 |
| US-11643616-B2 | Renewable base oil production engaging metathesis | FASN, DGAT2, GK | ALDH1A1 626/4885CYP19A1 734/4885OXER1 542/4885 |
| US-11795124-B2 | Renewable alkene production engaging metathesis | FASN, DGAT2, DGAT1 | ALDH1A1 202/4885CYP19A1 608/4885OXER1 420/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.